{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:12:34Z","timestamp":1789153954464,"version":"build-2803163510"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:p>\n                    Elevated levels of inflammatory cytokines and white blood cells (WBCs) have been observed in some patients with psychiatric disorders. However, the prevalence of leukocytosis, its association with psychiatric conditions, and its relevance in psychiatric outpatient care remain underexplored. This study included psychiatric outpatients who visited Akebono Clinic and underwent blood testing between October 2022 and September 2023. From patient records, we obtained age, sex, DSM-5-TR classification, and the highest and lowest WBC counts during the observation period. Leukocytosis was defined as an absolute WBC count exceeding 10,000 cells\/\u03bcL. Among the 1120 psychiatric outpatients included, 187 (16.7%) exhibited leukocytosis at least once during their visits. Ten (5.7%) of the 176 patients who underwent blood testing only once had leukocytosis. This percentage was significantly higher than that reported for the general Japanese population (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001). Leukocytosis exceeded 20% for patients with schizophrenia spectrum, bipolar and related, obsessive-compulsive and related, and personality disorders. The percentages were moderate (between 10% and 20%) for those with sleep-wake, depressive, anxiety, and neurodevelopmental disorders, and low (&lt;10%) for patients with somatic symptom and related, trauma- and stressor-related, and neurocognitive disorders. Leukocytosis had significantly higher percentages for those with schizophrenia spectrum, bipolar and related disorders, and depressive disorders than those for neurocognitive disorders (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.01,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.05, and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.05, respectively). Leukocytosis was observed in 20.5% of patients aged 30 to 69, 9.5% of those aged 10 to 29, and 8.7% of those aged 70 to 95, indicating significant differences in age groups. Leukocytosis was considerably more frequent in psychiatric patients than in the general population. Its prevalence was especially high, exceeding 20%, in patients with schizophrenia spectrum, bipolar and related, obsessive-compulsive and related, and personality disorders, and among middle-aged individuals.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043873","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:01:38Z","timestamp":1755543698000},"page":"e43873","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploratory study about the relationship between leukocytosis and mental disorders in psychiatric outpatients"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7966-9586","authenticated-orcid":false,"given":"Fumi","family":"Akasaka","sequence":"first","affiliation":[{"name":"Akebono Clinic, 26-1 Kaminakasone, Ishinomaki, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuni","family":"Akasaka","sequence":"additional","affiliation":[{"name":"Akebono Clinic, 26-1 Kaminakasone, Ishinomaki, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutake","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokai University Hospital, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Research Division, Saiseikai Research Institute of Health Care and Welfare, Minatoku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Haruki","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Science, Tokai University Hospital, Isehara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-3880","authenticated-orcid":false,"given":"Sotaro","family":"Sadahiro","sequence":"additional","affiliation":[{"name":"Akebono Clinic, 26-1 Kaminakasone, Ishinomaki, Miyagi, Japan"},{"name":"Department of Surgery, Tokai University Hospital, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJM193403222101206","article-title":"Leucocytosis in mental disease.","volume":"210","author":"Kasanin","year":"1934","journal-title":"New Engl J Med"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archneurpsyc.1942.02290050081006","article-title":"Leucocytosis during various emotional states.","volume":"47","author":"Milhorat","year":"1942","journal-title":"Arch Neurol Psych"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","article-title":"Inflammation and schizophrenia.","volume":"39","author":"Kirkpatrick","year":"2013","journal-title":"Schizophr Bull"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40120-015-0039-8","article-title":"The impact of red blood cell distribution width and neutrophil\/lymphocyte ratio on the diagnosis of major depressive disorder.","volume":"5","author":"Demircan","year":"2016","journal-title":"Neurol Ther"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psychres.2018.08.007","article-title":"Increased neutrophil-lymphocyte ratios in depressive adolescents is correlated with the severity of depression.","volume":"268","author":"\u00d6zyurt","year":"2018","journal-title":"Psychiatry Res"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jad.2018.05.079","article-title":"Depression and anxiety symptoms are associated with prooxidant-antioxidant balance: a population-based study.","volume":"238","author":"Shafiee","year":"2018","journal-title":"J Affect Disord"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1038\/s41598-022-13562-x","article-title":"Higher neutrophil-lymphocyte ratio is associated with depressive symptoms in Japanese general male population.","volume":"12","author":"Kinoshita","year":"2022","journal-title":"Sci Rep"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2005.06.001","article-title":"Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study.","volume":"185","author":"Pitsavos","year":"2006","journal-title":"Atherosclerosis"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/0004867416644508","article-title":"White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.","volume":"51","author":"K\u00f6hler","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000516340","article-title":"Peripheral leukocytosis predicts cognitive decline but not behavioral disturbances: a nationwide study of alzheimer\u2019s and parkinson\u2019s disease patients.","volume":"50","author":"Unda","year":"2021","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R14-20260911","first-page":"139","article-title":"Effect of lithium on leukocytes: a two-year follow-up.","volume":"44","author":"Pi","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"R15-20260911","first-page":"301","article-title":"The effects of lithium therapy on leukocytes: a 1-year follow-up study.","volume":"85","author":"Carmen","year":"1993","journal-title":"J Natl Med Assoc"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0004563215608875","article-title":"Collaborative derivation of reference intervals for major clinical laboratory tests in Japan.","volume":"53","author":"Ichihara","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"R17-20260911","first-page":"43","article-title":"Investigation on subjects with leukocytosis discovered in health check-ups at our hospital.","volume":"28","author":"Takahashi","year":"2013","journal-title":"Off J Jpn Soc Ningen Dock"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond.","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Schizophr Bull"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/ijms24010578","article-title":"Selected biomarkers of depression: what are the effects of cytokines and inflammation?","volume":"24","author":"Harsanyi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","article-title":"Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study.","volume":"79","author":"Williams","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/ATVBAHA.118.312338","article-title":"Smoking and increased white and red blood cells.","volume":"39","author":"Pedersen","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:01:02Z","timestamp":1789153262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":20,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043873","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}